StockNews.com Downgrades Select Medical (NYSE:SEM) to Hold

Select Medical (NYSE:SEM) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Wednesday.

SEM has been the subject of several other reports. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Royal Bank of Canada lifted their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, UBS Group dropped their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $39.50.

Select Medical Stock Up 1.8 %

Shares of SEM stock traded up $0.35 during trading hours on Wednesday, hitting $19.27. 767,805 shares of the company were exchanged, compared to its average volume of 922,353. The business’s 50-day simple moving average is $24.34 and its two-hundred day simple moving average is $31.32. Select Medical has a one year low of $18.02 and a one year high of $40.98. The stock has a market capitalization of $2.49 billion, a price-to-earnings ratio of 9.00, a P/E/G ratio of 0.39 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the business earned $0.46 EPS. The business’s quarterly revenue was up 5.7% on a year-over-year basis. Sell-side analysts predict that Select Medical will post 1.97 EPS for the current fiscal year.

Insider Activity

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now owns 22,000 shares of the company’s stock, valued at approximately $463,980. This trade represents a 59.26 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 17.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Quarry LP bought a new position in Select Medical during the 3rd quarter valued at $30,000. Canada Pension Plan Investment Board bought a new position in Select Medical during the second quarter valued at about $39,000. DekaBank Deutsche Girozentrale acquired a new position in Select Medical during the second quarter worth about $60,000. GAMMA Investing LLC raised its position in Select Medical by 16.6% in the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after acquiring an additional 330 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Select Medical in the 3rd quarter valued at about $81,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.